HTR4 and major depressive disorder: Such an effect supports the notion that new pharmacological antidepressant treatments that work on the 5-HT4R could also help in modulating corticolimbic circuitry subserving aberrant emotional response, a strong clinical risk factor of recurrence, relapse, and suicide risk in individuals affected by MDD [36–38].